Allergy & Immunology

Targeting RELMβ may provide new therapeutic strategies to prevent severe allergic reactions and improve patient outcomes.

The newly recommended immunotherapy works by gradually increasing the body’s resistance to house dust mites.

New research finds that a mother’s allergic disease and the season of her infant’s birth significantly influence the composition of the breast milk microbiome.

Early ACQ-5 score predicts mepolizumab treatment success in severe eosinophilic asthma, guiding clinical decisions.

New data from the COVAIL trial highlight the importance of neutralizing antibody titers in reducing COVID-19 risk after mRNA boosters, with stronger protection observed in individuals with prior SARS-CoV-2 infection.

This study highlights the potential of probiotics as an adjunct treatment for allergic rhinitis, offering symptom relief and improving quality of life.

Hydrolysed rice formulas offer unique advantages, such as accommodating cultural, religious, and economic preferences.

Specialist allergy care cuts asthma emergencies in Medicaid-enrolled children, improving outcomes and reducing healthcare visits.